| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.1907 | 14 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.3816 | 43 |
| GSM780709 | Untreated after 4 days (C3_1) | 40.2179 | 7 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.1691 | 14 |
| GSM780720 | Untreated after 4 days (C2_2) | 37.6405 | 2 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.3981 | 24 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.2645 | 42 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.0052 | 13 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.7832 | 31 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.3765 | 19 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.4948 | 34 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.4718 | 34 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.3224 | 55 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.1405 | 10 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 38.1084 | 3 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.0874 | 7 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 38.301 | 3 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.2711 | 52 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.0185 | 9 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.4633 | 20 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.9691 | 32 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.8303 | 26 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.811 | 21 |